search
Back to results

Transversus Abdominis Plane Block for Postoperative Analgesia in Living Donor Hepatectomy

Primary Purpose

Acute Pain

Status
Completed
Phase
Phase 4
Locations
Study Type
Interventional
Intervention
Transversus Abdominis Plane Block
standard general anesthesia
Sponsored by
Inonu University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Acute Pain focused on measuring transversus abdominis plane block, living liver transplantation, postoperative analgesia

Eligibility Criteria

18 Years - 65 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Liver transplantation donors

Exclusion Criteria:

  • Patients with a history of allergy to the drugs used in the study protocol, coagulation pathology, opioid tolerance

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Active Comparator

    Placebo Comparator

    Arm Label

    transversus abdominis plane block

    nonblocked

    Arm Description

    Patients who received a tranversus abdominis plane block with ultrasound after standard general anesthesia represented Group 1. The tranversus abdominis plane block was performed bilaterally by obtaining an image with real time ultrasound guidance with a 6-13 MHz linear probe. The block was placed with a 22 G 80 mm needle while obtaining real-time images via an in-plane technique. Two 20 mL syringes were prepared after preparing a local anesthetic concentration of 1.5 mg/kg of 0.5% bupivacaine to 40 mL with saline. These were administered to the left and right abdominal walls. Postoperative analgesia was administered through a morphine the patient-controlled analgesia device.

    Patients who received standard general anesthesia alone made up Group 2. Postoperative analgesia was administered through a morphine the patient-controlled analgesia device.

    Outcomes

    Primary Outcome Measures

    pain scores (at movement and at rest)
    Pain scores were assessed using a visual analog scale (0: No pain, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10: Excruciating pain).

    Secondary Outcome Measures

    morphine consumption
    morphine consumption were measured in postoperatively 24 hours

    Full Information

    First Posted
    December 24, 2015
    Last Updated
    January 5, 2016
    Sponsor
    Inonu University
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT02645903
    Brief Title
    Transversus Abdominis Plane Block for Postoperative Analgesia in Living Donor Hepatectomy
    Official Title
    Ultrasound-guided Transversus Abdominis Plane Block for Postoperative Analgesia in Living Donor Hepatectomy: Randomized Controlled Double-blinded Trial
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    January 2016
    Overall Recruitment Status
    Completed
    Study Start Date
    May 2015 (undefined)
    Primary Completion Date
    October 2015 (Actual)
    Study Completion Date
    October 2015 (Actual)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    Inonu University

    4. Oversight

    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    Living donor organ transplantation has increased in recent years due to an increased need for organs. The objective of this study was to investigate the effects of a TAP block on postoperative analgesia and opioid consumption in liver transplantation donors in whom a right lateral extending upper mid-line abdominal incision was used.
    Detailed Description
    This prospective randomized controlled double-blinded study was conducted with 50 liver transplantation donors between 18-65 years who were scheduled to undergo right hepatectomy surgery. Cases to whom TAP block with ultrasound was applied after standard general anesthesia were determined as Group 1 and cases to whom only standard general anesthesia was applied, were determined as Group 2.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Acute Pain
    Keywords
    transversus abdominis plane block, living liver transplantation, postoperative analgesia

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Phase 4
    Interventional Study Model
    Parallel Assignment
    Masking
    InvestigatorOutcomes Assessor
    Allocation
    Randomized
    Enrollment
    50 (Actual)

    8. Arms, Groups, and Interventions

    Arm Title
    transversus abdominis plane block
    Arm Type
    Active Comparator
    Arm Description
    Patients who received a tranversus abdominis plane block with ultrasound after standard general anesthesia represented Group 1. The tranversus abdominis plane block was performed bilaterally by obtaining an image with real time ultrasound guidance with a 6-13 MHz linear probe. The block was placed with a 22 G 80 mm needle while obtaining real-time images via an in-plane technique. Two 20 mL syringes were prepared after preparing a local anesthetic concentration of 1.5 mg/kg of 0.5% bupivacaine to 40 mL with saline. These were administered to the left and right abdominal walls. Postoperative analgesia was administered through a morphine the patient-controlled analgesia device.
    Arm Title
    nonblocked
    Arm Type
    Placebo Comparator
    Arm Description
    Patients who received standard general anesthesia alone made up Group 2. Postoperative analgesia was administered through a morphine the patient-controlled analgesia device.
    Intervention Type
    Drug
    Intervention Name(s)
    Transversus Abdominis Plane Block
    Other Intervention Name(s)
    Marcaine plain+morphine
    Intervention Description
    Cases to whom used bupivacaine with ultrasound guided transversus abdominis plane block was applied after standard general anesthesia were determined as Group 1
    Intervention Type
    Drug
    Intervention Name(s)
    standard general anesthesia
    Other Intervention Name(s)
    morphine
    Intervention Description
    Cases to whom applied alone standard general anesthesia were determined as Group 2
    Primary Outcome Measure Information:
    Title
    pain scores (at movement and at rest)
    Description
    Pain scores were assessed using a visual analog scale (0: No pain, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10: Excruciating pain).
    Time Frame
    postoperatively at 24 hours
    Secondary Outcome Measure Information:
    Title
    morphine consumption
    Description
    morphine consumption were measured in postoperatively 24 hours
    Time Frame
    postoperatively at 24 hours

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Maximum Age & Unit of Time
    65 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: Liver transplantation donors Exclusion Criteria: Patients with a history of allergy to the drugs used in the study protocol, coagulation pathology, opioid tolerance
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Mehmet Ali Erdogan
    Organizational Affiliation
    Inonu University
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Plan to Share IPD
    No
    Citations:
    PubMed Identifier
    22286518
    Citation
    Abdallah FW, Chan VW, Brull R. Transversus abdominis plane block: a systematic review. Reg Anesth Pain Med. 2012 Mar-Apr;37(2):193-209. doi: 10.1097/AAP.0b013e3182429531.
    Results Reference
    result

    Learn more about this trial

    Transversus Abdominis Plane Block for Postoperative Analgesia in Living Donor Hepatectomy

    We'll reach out to this number within 24 hrs